TiffanySang-MeeHanMD

Physician

Dr. Han is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

39 citations
NMR-based mapping of disulfide bridges in cysteine-rich peptides: Application to the μ-conotoxin SxIIIA
Aleksandra Walewska, Jack J. Skalicky, Darrell R. Davis, Min Min Zhang, Estuardo López-Vera
Journal of the American Chemical Society. 2008-10-29
144 citations
Conus Venoms : A Rich Source of Peptide-Based Therapeutics
Tiffany S. Han, Russell W. Teichert, Baldomero M. Olivera, Grzegorz Bulaj
Current Pharmaceutical Design. 2008-07-31
7 citations
Expanding chemical diversity of conotoxins: peptoid-peptide chimeras of the sodium channel blocker μ-KIIIA and its selenopeptide analogues.
Aleksandra Walewska, Tiffany S. Han, Min Min Zhang, Doju Yoshikami, Grzegorz Bulaj
European Journal of Medicinal Chemistry. 2013-07-01

Abstracts/Posters

"Autism, Neuroligin, and Synaptic Architecture"
Tiffany Han, Dylan Hale, Thomas Sudhof, Research Symposium, University of Utah, 4/2014
"Interactions of Disulfide-Deficient Analogs of Mu-Conotoxin KIIIA with Voltage-Gated Sodium Channels: Stability-Activity Relationships"
Han,T., Zhang, M., Walewska, A., Yoshikami, D., Olivera, BM., Bulaj, G., NCUR 2009, Lacrosse, Wisconsin, 4/2009
"Engineering Conopeptide-Based Therapeutics for Pain"
Han, T., Walewska, A., Zhang, M., Yoshikami, D., Bulaj, G., Olivera, B., National Conference for Undergraduate Research, Salisbury, Maryland, 4/1/2008
"Engineering Conopeptide-Based Therapeutics for Pain"
Han, T. Walewska, A., Zhang, M, Yoshikami, D., Bulaj, G., Olivera, B., Posters on the Hill, Utah State Capitol, 1/2008
Join now to see all

Lectures

HHMI Summer Medical ResearchResearch was done in Dr. Thomas Südhof's lab at Stanford University. Designed DNA constructs of post-synaptic protein, neuroligin, to understand its critical role for the expression of synaptic receptors and synaptic scaffolding and down-stream neurotransmission.2014 - 2014
Korenberg Lab, Department of Neuroscience, University of UtahConducted research in Dr. Julie Korenberg's lab, part of the Brain Institute at the Univ. of Utah. Lab focuses on the neurobiology of human neurodevelopmental disorders, namely Down syndrome and Williams syndrome. Mapped gene expression in Williams, Down syndrome and Autism patients.2010 - 2011
Fulbright Research FellowshipConducted research at the Univ. of Gdansk in Poland. Designed and synthesized neuroactive peptide derivatives in an attempt to stabilize potential drugs for chronic pain sufferers in the digestive system.2009 - 2010
Olivera Lab, Department of Biology, University of UtahFocused on the discovery and development of neuroactive peptides, found in the venom of marine predatory cone snails, for the treatment of neurological disorders. Peptides have high affinity for a receptor targets which are validated for treating epilepsy, chronic pain, and Parkinson's disease.2007 - 2009